// App-Quantinova.ai

100 : The detrimental side effects of therapeutic glucocorticoids on bone are mediated by their local reactivation by 11β-hydroxysteroid dehydrogenase type 1

Researchers

Presenter

  • Chloe Fenton

Principal Investigators

  • Craig Doig

  • Karim Raza

  • Mark Cooper

  • Gareth Lavery

  • Rowan Hardy

Medical Centers

  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom

  • Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom

  • ANZAC Research Institute, University of Sydney, Sydney, AUSTRALIA

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved